Ontex Group NV
Change company Symbol lookup
Select an option...
ONXXF Ontex Group NV
LOTZ Carlotz Inc
TSLA Tesla Inc
INN Summit Hotel Properties Inc
NCNO nCino Inc
FISK Empire State Realty OP LP
RMD Resmed Inc
BST BlackRock Science and Technology Trust
MPW Medical Properties Trust Inc
UWHR Uwharrie Capital Corp
Go


Based in Belgium
Company profile

Ontex Group NV is a Belgium-based company, which operates in the manufacturing industry. The Company is a producer of disposable personal hygiene solutions for babies, women and adults. It offers a range of such products as baby diapers, baby pants, baby wet wipes, pads, pantyliners, tampons, light incontinence products, pull-ups, belt diapers, all-in-one tape systems, shaped pads and underpards. Its products are distributed through retail partner brands, as well as under its own brands (canbebe, canped and Moltex,) across several distribution channels, such as retail trade, care institutions and pharmacies. The Company is present in Europe, North America, Brazil, Northern Africa, Australia and Asia, among others.

Closing Price
$8.87
Day's Change
0.00 (0.00%)
Bid
--
Ask
--
B/A Size
--
Day's High
--
Day's Low
--
Volume
(Light)
Volume:
0

10-day average volume:
6,843
0

LAWSUITS FILED AGAINST SAM, EAR and SBTX - Jakubowitz Law Pursues Shareholders Claims

12:02 pm ET November 12, 2021 (Accesswire) Print

NEW YORK, NY / ACCESSWIRE / November 12, 2021 / Jakubowitz Law announces that securities fraud class action lawsuits have commenced on behalf of shareholders of the following publicly-traded companies who purchased shares within the class periods listed below. Shareholders interested in representing the class of wronged shareholders have until the lead plaintiff deadline to petition the court. Your ability to share in any recovery doesn't require that you serve as a lead plaintiff. For more details and to speak with our firm without cost or obligation, follow the links below.

The Boston Beer Company, Inc. (NYSE:SAM)

CONTACT JAKUBOWITZ ABOUT SAM:

https://claimyourloss.com/securities/the-boston-beer-company-inc-loss-submission-form/?id=21135&from=1

Class Period : April 22, 2021 - September 8, 2021

Lead Plaintiff Deadline : November 15, 2021

The filed complaint alleges that defendants made materially false and/or misleading statements and/or failed to disclose that: (1) Boston Beer's hard seltzer sales were decelerating; (2) as a result, Boston Beer was reasonably likely to incur inventory write-offs; (3) the Company was reasonably likely to incur shortfall fees payable to third party brewers; (4) as a result of the foregoing, Boston Beer's financial results would be adversely impacted; and (5) as a result of the foregoing, Defendants' positive statements about the Company's business, operations, and prospects were materially misleading and/or lacked a reasonable basis.

Eargo, Inc. (NASDAQ:EAR)

CONTACT JAKUBOWITZ ABOUT EAR:

https://claimyourloss.com/securities/eargo-inc-loss-submission-form/?id=21135&from=1

This lawsuit is on behalf of all persons or entities that purchased or otherwise acquired: (a) Eargo shares in or traceable to the Company's initial public offering of common stock conducted on or around October 15, 2020 (the "Offering"); and/or (b) shares of Eargo common stock between October 15, 2020 and September 22, 2021, inclusive.

Lead Plaintiff Deadline : December 6, 2021

The filed complaint alleges that defendants made materially false and/or misleading statements and/or failed to disclose that: (1) Eargo had improperly sought reimbursements from certain third-party payors; (2) the foregoing was reasonably likely to lead to regulatory scrutiny; (3) as a result and because the reimbursements at issue involved the Company's largest third-party payor, Eargo's financial results would be adversely impacted; and (4) as a result of the foregoing, Defendants' positive statements about the Company's business, operations, and prospects were materially misleading and/or lacked a reasonable basis.

Silverback Therapeutics, Inc. (NASDAQ:SBTX)

CONTACT JAKUBOWITZ ABOUT SBTX:

https://claimyourloss.com/securities/silverback-therapeutics-inc-loss-submission-form/?id=21135&from=1

This lawsuit is on behalf of a class consisting of all persons and entities other than Defendants that purchased or otherwise acquired: (a) Silverback common stock pursuant and/or traceable to the Offering Documents (defined below) issued in connection with the Company's initial public offering conducted on or about December 3, 2020 and/or (b) Silverback securities between December 3, 2020 and September 10, 2021, both dates inclusive.

Lead Plaintiff Deadline : January 4, 2022

The filed complaint alleges that defendants made materially false and/or misleading statements and/or failed to disclose that: (i) Silverback's lead product candidate SBT6050, which is in a Phase I/Ib clinical trial, a TLR8 agonist linker-payload conjugated to a HER2-directed monoclonal antibody that targets tumors, such as breast, gastric, and non-small cell lung cancers, was less effective than the Company had represented to investors; (ii) accordingly, the Company had overstated SBT6050's commercial and/or clinical prospects; and (iii) as a result, the Offering Documents and Defendants' public statements throughout the Class Period were materially false and/or misleading and failed to state information required to be stated therein.

Image: https://www.accesswire.com/users/newswire/images/672629/Jakubowitz_CTA-1.png

Jakubowitz Law is vigorous in pursuit of justice for shareholders who have been the victim of securities fraud. Attorney advertising. Prior results do not guarantee similar outcomes.

CONTACT:

JAKUBOWITZ LAW

1140 Avenue of the Americas

9th Floor

New York, New York 10036

T: (212) 867-4490

F: (212) 537-5887

SOURCE: Jakubowitz Law

View source version on accesswire.com:

https://www.accesswire.com/672629/LAWSUITS-FILED-AGAINST-SAM-EAR-and-SBTX--Jakubowitz-Law-Pursues-Shareholders-Claims

comtex tracking

COMTEX_396796550/2457/2021-11-12T12:02:20

Earnings Calendar and Events Data provided by |Terms of Use| © 2022 Wall Street Horizon, Inc.

Market data accompanied by is delayed by at least 15 minutes for NASDAQ, NYSE MKT, NYSE, and options. Duration of the delay for other exchanges varies.
Market data and information provided by Morningstar.

Options are not suitable for all investors as the special risks inherent to options trading may expose investors to potentially rapid and substantial losses.
Please read Characteristics and Risks of Standard Options before investing in options.

Information and news provided by ,, , Computrade Systems, Inc., ,, and

Copyright © 2022. All rights reserved.